InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Pronovost Peter, Director. Officer active across 1 company, notably Cantel Medical CORP. In total, 2 disclosures have been published. Activity tracked since 2 June 2021. The latest transaction was disclosed on 2 June 2021 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
22,970.431 shares@ US$80.5950.0% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075863
22,970.431 shares@ US$80.5950.0% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075863:0
2 of 2 declarations
About Pronovost Peter
Peter Pronovost is a Director at CANTEL MEDICAL CORP. In this role, he contributes to the governance of the company and strategic direction. His experience in the medical sector allows him to make significant contributions to the company's leadership.
